Peptides Targeting HER2-Positive Breast Cancer Cells and Applications in Tumor Imaging and Delivery of Chemotherapeutics
Breast cancer represents the most common cancer type and one of the major leading causes of death in the female worldwide population. Overexpression of HER2, a transmembrane glycoprotein related to the epidermal growth factor receptor, results in a biologically and clinically aggressive breast cance...
Main Authors: | Palmira Alessia Cavallaro, Marzia De Santo, Emilia Lucia Belsito, Camilla Longobucco, Manuela Curcio, Catia Morelli, Luigi Pasqua, Antonella Leggio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/13/17/2476 |
Similar Items
-
HER3 signaling and targeted therapy in cancer
by: Rosalin Mishra, et al.
Published: (2018-05-01) -
Leptin-Activity Modulators and Their Potential Pharmaceutical Applications
by: Marianna Greco, et al.
Published: (2021-07-01) -
Titanium Tetrachloride-Assisted Direct Esterification of Carboxylic Acids
by: Palmira Alessia Cavallaro, et al.
Published: (2024-02-01) -
Development of Highly Sensitive Anti-Mouse HER2 Monoclonal Antibodies for Flow Cytometry
by: Tsunenori Ouchida, et al.
Published: (2023-08-01) -
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer
by: Emma Franco-Mateos, et al.
Published: (2024-04-01)